NCT05827523 2026-02-13
FOCUS / KOV-04
National Cancer Center, Korea
Phase 3 Recruiting
Clinical Trials
6 trialsNCT07121322 2025-08-13
DACT-GCT
National Cancer Institute, Slovakia
Phase 2 Recruiting
NCT07050043 2025-07-03
LEDANG
Hospital Sultanah Bahiyah
Phase 3 Recruiting
NCT06156514 2025-05-28
MICHELE
National Institute of Cancerología
Phase 3 Recruiting
NCT06670911 2025-02-24
ACCESS-I
Instituto Nacional de Cancer, Brazil
Phase 2 Recruiting
NCT05910177 2024-03-06
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
Fujian Cancer Hospital
Phase 2 Recruiting